Skip to content
About
About Us
Team & Board
Generic Medicines
Our Members
Advocacy & Policy
Overview
Federal Advocacy
State Advocacy
Tariff & Trade
Biosimilars
GDUFA/BsUFA User Fees
IP & Patent Reform
Inflation Reduction Act
Medicaid Generics Penalty
Resources
Resource Center
Generic & Biosimilar
Medicines Savings Report
Advocacy Priorities
Biosimilars
Events
All Events
GRx+Biosims 2026
Access! 2027
About
About Us
Team & Board
Generic Medicines
Our Members
Advocacy & Policy
Overview
Federal Advocacy
State Advocacy
Tariff & Trade
Biosimilars
GDUFA/BsUFA User Fees
IP & Patent Reform
Inflation Reduction Act
Medicaid Generics Penalty
Resources
Resource Center
Generic & Biosimilar
Medicines Savings Report
Advocacy Priorities
Biosimilars
Events
All Events
GRx+Biosims 2026
Access! 2027
JOIN
SEARCH
Home
Blog
Biosimilars Council Press Releases
Blog
Blog
October 20, 2020
AAM
Adding up the Generic Savings for Americans with Cancer and Other Conditions
Blog
October 15, 2020
AAM
Jeni Got Her Life Back, Thanks to a Biosimilar
Blog
September 29, 2020
AAM
Securing Access and Savings: By the Numbers
Blog
September 24, 2020
Founders Series
Thank you, Rep. Henry Waxman
Blog
September 18, 2020
AAM
Member Spotlight: Apotex
Blog
September 9, 2020
AAM
Generics: The Bridge to A Vaccine
Blog
August 24, 2020
AAM
2020 Report
Blog
July 30, 2020
Founders Series
Thank you, Carole Ben-Maimon
Blog
July 29, 2020
AAM
GRx+Biosims 2020: Join Us Virtually November 9-11
Blog
July 1, 2020
AAM
Why—and How—the U.S. Should Develop a List of Essential Medicines
Blog
June 29, 2020
AAM
America’s Patients: Share Your Story
Blog
June 26, 2020
Founders Series
Thank you, Desh Bandhu Gupta
Load More
Resources
2025 Savings Report
2025 Advocacy Priorities
2025 First Generics White Paper
Drug Shortages White Paper
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Blog
Founders Blogs
Amicus Briefs
Patient Stories
About the Association
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Community Commitment
Careers
Contact Us
Advocacy & Policy
Federal Advocacy
Biosimilars
GDUFA/BsUFA User Fees
Inflation Reduction Act
Intellectual Property & Patent Reform
Medicaid Generics Penalty
State Advocacy
Tariffs & Trade
Events
Access! 2026
GRx+Biosims 2026
Press Releases
JOIN
About
About Us
Team & Board
Generic Medicines
Our Members
Advocacy & Policy
Overview
Federal Advocacy
State Advocacy
Tariff & Trade
Biosimilars
GDUFA/BsUFA User Fees
IP & Patent Reform
Inflation Reduction Act
Medicaid Generics Penalty
Resources
Resource Center
Generic & Biosimilar
Medicines Savings Report
Advocacy Priorities
Biosimilars
Events
All Events
GRx+Biosims 2026
Access! 2027
JOIN
SEARCH
